Matthew S. Abbott - 08 May 2024 Form 4 Insider Report for Chemours Co (CC)

Reporting relationship
Interim CFO
Issuer ticker
CC
Reported as of
08 May 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 May 2024, 16:03:32 UTC
Prior SEC filing
29 Mar 2024
Next SEC filing
05 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nicole Perez Lengel, Attorney-in-Fact

Key filing fact

Matthew S. Abbott filed Form 4 for Chemours Co (CC) on 10 May 2024.

Key facts

  • This page summarizes Matthew S. Abbott's Form 4 filing for Chemours Co (CC).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 10 May 2024, 16:03.

Change

  • Previous filing in this sequence was filed on 29 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Award

Transaction value
$0
Shares
+11,818
Change %
+34%
Price
$0.000000
Shares after
46,106
Date
08 May 2024
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+31,614
Change %
Price
$0.000000
Shares after
31,614
Date
08 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,614
Exercise price
$27.50
Footnotes
F3
CC transaction Derivative

Performance Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+32,879
Change %
Price
$0.000000
Shares after
32,879
Date
08 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,879
Exercise price
$30.25
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.

Footnote F2

Includes directly owned shares, restricted stock units and dividend equivalent units.

Footnote F3

These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.

Footnote F4

Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .